Jupiter Neurosciences- Warrants(19/11/2026) Return on Equity

Jupiter Neurosciences- Warrants(19/11/2026)'s return on equity stands at 3.3%. That is above the sector sector average of -4.03%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Jupiter Neurosciences- Warrants(19/11/2026) sits higher the its sector benchmark (-4.03%) with a ROE of 3.3%. That is roughly 8292.1% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of 3.3% for Jupiter Neurosciences- Warrants(19/11/2026) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Jupiter Neurosciences- Warrants(19/11/2026)'s ROE evolved across reporting periods, while the comparison chart places JUNSW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.